Get the Stockscreener App
9.42
1.10%
-0.13
Electrocore Inc stock is traded at $9.42, with a volume of 78,894.
It is down -1.10% in the last 24 hours and down -45.75% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$9.55
Open:
$9.58
24h Volume:
78,894
Relative Volume:
0.56
Market Cap:
$64.96M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-2.6914
EPS:
-3.5
Net Cash Flow:
$-14.87M
1W Performance:
-33.01%
1M Performance:
-45.75%
6M Performance:
+54.84%
1Y Performance:
+55.09%
1-Day Range:
$9.01
$9.94
1-Week Range:
$9.01
$14.01
52-Week Range:
$5.32
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
9.50 | 64.96M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
126.15 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.12 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
368.77 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.94 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.33 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
H.C. Wainwright maintains Buy on electroCore stock, $25 target - Investing.com India
electroCore, Inc. (NASDAQ:ECOR) Q4 2024 Earnings Call Transcript - Insider Monkey
electroCore Inc (ECOR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
ElectroCore Reports Strong 2024 Financial Growth - TipRanks
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
electroCore, Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
electroCore Announces Full Year 2024 Financial Results - TradingView
Vagus Nerve Stimulators Market Generated Opportunities, - openPR
Gadsden Properties (OTCMKTS:GADS) vs. electroCore (NASDAQ:ECOR) Critical Contrast - Defense World
ELECTROCORE Earnings Preview: Recent $ECOR Insider Trading, Hedge Fund Activity, and More - Nasdaq
(ECOR) On The My Stocks Page - Stock Traders Daily
electroCore, Inc. to Host Earnings Call - ACCESS Newswire
electroCore to Announce Fourth Quarter and Full Year Ended - GlobeNewswire
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025 - The Manila Times
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, - EIN News
electroCore to Participate at Upcoming Investor Conferences - GlobeNewswire
Electrocore To Participate At Upcoming Investor Conferences - MENAFN.COM
Meet electroCore Executives: Two Major Investor Conferences Scheduled for March 2025 - StockTitan
electroCore (ECOR) to Release Earnings on Wednesday - Defense World
electroCore Board Reshuffle as Director Resigns By Investing.com - Investing.com Australia
electroCore Board Reshuffle as Director Resigns - Investing.com India
Electrocore Board Restructures After Director Resignation - TipRanks
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal - The Manila Times
electroCore, Inc. to Distribute Sparrow Ascent™ for Opioid Withdrawal in Veterans Affairs Facilities - Nasdaq
Can This New Partnership Help Veterans Combat Opioid Withdrawal? electroCore Expands Treatment Options - StockTitan
electroCore’s Truvaga™ Now Available on Amazon® - GlobeNewswire
ElectroCore expands reach with Amazon listing for Truvaga Plus By Investing.com - Investing.com Australia
ElectroCore expands reach with Amazon listing for Truvaga Plus - Investing.com India
electroCore's Truvaga™ Now Available on Amazon® - The Manila Times
This FDA-Cleared Device Claims to Reduce Stress and Improve SleepNow Available on Amazon - StockTitan
electroCore Insider Buyers See Boost After Market Cap Rose US$11m - Simply Wall St
ElectroCore stock soars to 52-week high, hits $18.77 - Investing.com India
ElectroCore stock soars to 52-week high, hits $18.77 By Investing.com - Investing.com South Africa
What Makes electroCore (ECOR) a High Growth And High Margin Business? - Insider Monkey
electroCore, Inc. (NASDAQ:ECOR) Short Interest Up 34.5% in January - MarketBeat
How to Take Advantage of moves in (ECOR) - Stock Traders Daily
Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why - Nasdaq
electroCore secures two new US patents for nerve therapy - MSN
electroCore secures two new US patents for nerve therapy By Investing.com - Investing.com Nigeria
electroCore Expands Intellectual Property Portfolio - GlobeNewswire
Breakthrough Patents Bolster electroCore's Nerve Stimulation Tech: Smart Monitoring Meets Precision Treatment - StockTitan
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GANDOLFO JOHN P | Director |
Jun 13 '24 |
Buy |
6.43 |
1,000 |
6,430 |
50,704 |
| Goldberger Daniel S | Chief Executive Officer |
Jun 05 '24 |
Buy |
6.43 |
38,505 |
247,587 |
249,565 |
0.57%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):